首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Streamlining Disease Risk Analysis for Wildlife Using the Shark Bay Bandicoot as a Model
Authors:Vaughan-Higgins  Rebecca J  Vitali  Simone D  Sims  Colleen  Page  Manda  Reiss  Andrea
Institution:1.Conservation Medicine Program, College of Veterinary Medicine, School of Veterinary and Life Sciences, Murdoch University, South Street, Murdoch, WA, 6150, Australia
;2.Veterinary Department, Perth Zoo, 20 Labouchere Rd, South Perth, WA, 6151, Australia
;3.Biodiversity and Conservation Science Division, Department of Biodiversity Conservation and Attractions, Woodvale Wildlife Research Centre, Wildlife Place, Woodvale, 6026, Australia
;4.Biodiversity and Conservation Science Division, Department of Biodiversity, Conservation and Attractions, 17 Dick Perry Avenue, Technology Park Western Precinct, Kensington, 6151, Australia
;5.Wildlife Health Australia, Suite E, 34 Suakin Drive, Mosman, NSW, 2088, Australia
;
Abstract:

Disease risk analysis (DRA) is a process for identifying significant disease risks and proposing measures to mitigate those risks. Although numerous methodologies for DRA exist, the IUCN Disease Risk Analysis Manual Jakob-Hoff et al. (World Organisation for Animal Health, Paris, pp 160, 2014) remains the gold standard for wild animal translocations. In some cases, however, constraints of time or resources demand compromises on the ideal methodology, and a cost–benefit assessment is required to determine the best approach. We propose a methodology modified from Jakob-Hoff et al. (World Organisation for Animal Health, Paris, pp 160, 2014) and Sainsbury and Vaughan-Higgins (Conserv Biol 26:442–452, 2012), using translocations of the Shark Bay bandicoot (SBB) (Perameles bougainville) as an example. In this study, 44 hazards were identified and described for Peramelidae species. We used hazard prioritization and “scoping” to develop a shortlist of hazards for detailed risk assessment, which excluded 35 of these hazards from further assessment. This approach enabled timely, efficient and cost-effective completion of the DRA while maintaining transparent evaluation of all disease risks. We developed a disease risk management strategy for SBB based on structured, evidence-based analysis of current information and established biosecurity practices and disease screening recommendations for future translocations. Our approach demonstrates a practical process for DRA and risk mitigation, which delivered management outcomes despite limited resources, variable knowledge of disease epidemiology and uncertain translocation pathways for the target species. Limitations are acknowledged, and further research will aim to objectively test this methodology compared to other available methods.

Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号